Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease

55

Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease

Tags:

Previous Article

Promising drug for aggressive breast cancer

Treating metabolic dysfunction-associated steatotic liver disease with precision...

Related Posts

Endogenous structure of antimalarial target PfATP4 reveals an apicomplexan-specific P- type ATPase modulator

Endogenous structure of antimalarial target PfATP4 rev...

34

NEUROPILIN-1 INHIBITION SUPPRESSES NERVE-GROWTH FACTOR SIGNALING AND NOCICEPTION IN PAIN MODELS

NEUROPILIN-1 INHIBITION SUPPRESSES NERVE-GROWTH FACTOR ...

84

Pathogen-responsive alternative splicing in plant immunity

Pathogen-responsive alternative splicing in plant immunity

68